INTANGIBLE ASSETS (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Finite-Lived Intangible Assets
Accumulated Amortization	$ (216,725)	$ (200,626)
Indefinite-Lived Intangible Assets
Gross Carrying Amount	2,714,085	2,606,598
Net Amount	2,497,360	2,405,972
Hormone Therapy Drug Candidate Patents - (Pending) [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,298,667	1,203,987
Net Amount	1,298,667	1,203,987
Multiple Trademarks [Member]
Indefinite-Lived Intangible Assets
Gross Carrying Amount	190,940	185,465
Net Amount	190,940	185,465
Opera Software Patent [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	31,951	31,951
Accumulated Amortization	(6,989)	(6,490)
Net Amount	$ 24,962	$ 25,461
Weighted average remaining amortization period	12 years 6 months	12 years 9 months
Development Costs Of Corporate Website [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 91,743	$ 91,743
Accumulated Amortization	(91,743)	(91,743)
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,100,784	1,093,452
Accumulated Amortization	(117,993)	(102,393)
Net Amount	$ 982,791	$ 991,059
Weighted average remaining amortization period	15 years 9 months	16 years